Gene editing advance shows promise as long-lasting treatment for rare liver disease

Дата публикации: 11-09-2026 16:20:09

Researchers have taken an important step toward solving one of the biggest challenges in gene therapy for children with metabolic liver disorders: growth itself. As a child's liver grows, some gene therapies that once worked can gradually lose their effect because the treated cells are eventually outnumbered by new, untreated ones.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New approach to gene correction for iron storage disease	2	7	09-07-2026
2	Mayo Clinic discovers rare gene mutation that causes fatty liver disease	0	7.1	07-03-2026
3	Создана технология для решения проблемы редозирования в генной терапии	0	0	20-01-2026
4	FDA approves gene therapy for children with sickle cell disease ages 2+	5	7	09-07-2026
5	Прорыв в области редактирования генов вызывает беспокойство насчет детей	0	7	09-07-2026
6	The surprising therapy targeting the liver which could protect brain from Alzheimer's	0	9.85	16-06-2026
7	‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That	5	7	21-07-2026
8	Boosting a key brain protein could help treat Rett syndrome	0	8.25	07-03-2026
9	New platform combines precision gene targeting with brain-wide delivery	0	11.38	08-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 9.31. Источник: medicalxpress.com.